Usana Health Sciences (USNA) Operating Income (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Operating Income data on file, last reported at $13.9 million in Q2 2026.

• Operating Income for Q2 2026 came in at $13.9 million, down 11.47% year-over-year; the trailing twelve-month figure through Apr 2026 was $35.6 million (down 37.83% YoY), and the FY2026 annual result was $37.4 million, down 43.56% from the prior year.
• Operating Income rose to $13.9 million in Q2 2026 per USNA's latest filing, from $3.8 million in the prior quarter.
• Over five years, Operating Income peaked at $46.2 million in Q1 2022 and troughed at $1.2 million in Q3 2025.
• A 5-year average of $20.3 million and a median of $20.2 million in 2022 frame the typical range for Operating Income.
• The sharpest annual moves came in 2023 and 2025: Operating Income increased 7.4% in 2023, then plunged 92.15% in 2025.
• A 5-year view of Operating Income shows it stood at $22.6 million in 2022, then advanced by 7.4% to $24.2 million in 2023, then sank by 66.1% to $8.2 million in 2024, then slumped by 85.09% to $1.2 million in 2025, then soared by 1033.5% to $13.9 million in 2026.
• Business Quant data shows USNA's Operating Income at $13.9 million in Q2 2026, $3.8 million in Q1 2026, and $1.2 million in Q3 2025.